Stockreport

FDA OKs expanded use of Astellas and Pfizer's Xtandi [Seeking Alpha]

ASTELLAS PHARMA UNSP/ADR  (ALPMY) 
NASDAQ:AMEX Investor Relations: astellas.com/jp/en/investors
PDF Astellas Pharma ( OTCPK:ALPMF PFE announce The androgen receptor inhibitor was approved in the U.S. in August 2012 for metastatic castration-resistant prostate cancer an [Read more]